As summer turns to autumn, the global pharmaceutical industry will once again gather in Milan, Italy's capital of fashion and design, in 2024. The highly anticipated CPHI Milan 2024 will be held at the Fiera Milano from October 8th to 10th. As one of the world's largest pharmaceutical exhibitions, CPHI Milan is not only a platform for showcasing the latest products and technologies, but also a key venue for promoting communication and collaboration within the global pharmaceutical industry.

As summer transitions into autumn, the global pharmaceutical industry is set to gather once again in Milan, the vibrant capital of fashion and design, for the highly anticipated CPHI Milan Show 2024. From October 8th to 10th, the Milan International Exhibition Center (Fiera Milano) will host one of the world's largest and most renowned pharmaceutical events. This premier exhibition will not only showcase the latest products and technologies but will also serve as a key platform for industry professionals to connect, collaborate, and exchange ideas.

10.8-102024 Milan CPHI Pharmaceutical Exhibition

Themed “At the Heart of the Pharma Industry,” the show celebrates 35 years of the CPHI series of exhibitions uniting the pharmaceutical industry and is expected to attract 62,000 attendees and 2,400 exhibiting companies from more than 166 countries worldwide, including more than 150 leading international expert speakers who will share their insights and experiences in more than 100 content sessions.
This year's show, themed “At the Heart of Pharma,” marks the 35th anniversary of the CPHI series. It will welcome over 62,000 participants and 2,400 exhibitors from more than 166 countries, along with over 150 leading international experts who will share their knowledge through 100+ insightful conference sessions.

Fushine Pharmaceuticals booth information

Fushine Pharmaceuticals sincerely invites you to attend the 2024 CPHI Milan. CPHI Milan is not only a platform for showcasing products and technologies, but also a valuable opportunity for global pharmaceutical professionals to exchange ideas and share resources. On this stage filled with both opportunities and challenges, let us witness every leap forward in the pharmaceutical industry and work together to create a brighter future. We look forward to joining you in Milan in the golden autumn of October to celebrate this event and witness the innovation and development of the pharmaceutical industry.Fushine Pharmaceuticals welcomes you at booth 4B110!
Fushine Pharmaceutical warmly invites you to attend the 2024 CPHI Milan Exhibition. This event is not just a showcase of products and technologies but a unique opportunity for global pharmaceutical professionals to network and share resources. Join us as we explore the challenges and opportunities of the pharmaceutical industry and work together to create a brighter future. We look forward to meeting you this autumn in Milan and welcome you to booth 4B110!

About Fushine Pharmaceuticals

As a major global supplier of sulbactam and tazobactam products, one of the few major domestic manufacturers of carbapenem penem products with a full industry chain layout from starting materials to downstream APIs, and a major global supplier of clovir intermediates, Fushine Pharmaceuticals takes "meticulous pharmaceutical production, caring for health" as its mission. Over the years, it has been deeply engaged in the pharmaceutical industry, focusing on antiviral and antibacterial drugs. It enjoys a good reputation and achieves win-win cooperation with domestic and foreign customers. Its products are sold to dozens of countries and regions around the world. It is a national high-tech enterprise, a national intellectual property advantage enterprise, a single champion enterprise in the manufacturing industry of Jiangxi Province, an outstanding enterprise in Jiangxi Province, and an innovative pilot enterprise in Jiangxi Province. It has been selected as one of the top 100 Chinese chemical pharmaceutical companies for many years!
As a leading global supplier of sulbactam and tazobactam products, a major manufacturer of carbapenem antibiotics from raw materials to finished APIs, and a top provider of key intermediates for antiviral drugs, Fushine Pharmaceutical takes pride in its commitment to healthcare. With a strong focus on antiviral and antibacterial therapies, we have earned a solid reputation among customers worldwide, fostering successful partnerships and expanding our reach to numerous countries and regions. We are proud to be recognized as a National High-Tech Enterprise, a National Intellectual Property Advantage Enterprise, a Manufacturing Champion of Jiangxi Province, and one of the Top 100 Chemical Pharmaceutical Ente and one of the Top 100 Chemical Pharmaceutical Ente and one of the Top 100 Chemical Pharmaceutical Enterprises in China.
Relying on the quality management and EHS management capabilities accumulated over many years of experience in the pharmaceutical industry, solid process development and high-standard large-scale production and manufacturing capabilities, we vigorously develop the lithium battery electrolyte additive business and synthetic biology microbial protein business, and are committed to becoming a world-renowned pharmaceutical company, a major global supplier of new energy materials, and a global leading microbial protein manufacturer.
Leveraging our decades of expertise in quality management, EHS standards, and large-scale production, we are also expanding into new industries, such as lithium battery electrolyte additives and synthetic biology-based mycoprotein. Our goal is to become a globally recognized pharmaceutical company, a leading supplier of new energy materials, and a pioneer in mycoprotein production.